% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/inflammatory_markers.R
\name{inflammatory_markers}
\alias{inflammatory_markers}
\title{Compute inflammatory indices (classic, eosinophil, or both)}
\usage{
inflammatory_markers(
  data,
  col_map,
  panel = c("auto", "classic", "eos", "both"),
  na_action = c("error", "omit", "keep"),
  check_extreme = FALSE,
  extreme_action = c("warn", "cap", "error", "ignore", "NA"),
  verbose = FALSE
)
}
\arguments{
\item{data}{data.frame or tibble}

\item{col_map}{named list mapping keys to column names in \code{data}.
Keys: neutrophils, lymphocytes, monocytes, platelets, WBC, CRP, albumin, eosinophils, ESR.}

\item{panel}{one of c("auto","classic","eos","both"). "auto" uses presence of eosinophils key.}

\item{na_action}{one of c("error","omit","keep")}

\item{check_extreme}{logical; if TRUE, handle extremes per \code{extreme_action}}

\item{extreme_action}{one of c("warn","cap","error","ignore","NA")}

\item{verbose}{logical; if TRUE, prints progress messages via hm_inform}
}
\value{
tibble with selected inflammatory indices
}
\description{
Panels:
\itemize{
\item classic: NLR, PLR, LMR, dNLR, SII, SIRI, AISI, CRP_category
\item eos:     NLR, PLR, LMR, NER, SII, SIRI, PIV, CLR, CAR, PCR, mGPS, ESR (if mapped)
\item both:    union of classic and eos panels
}
}
\details{
Derived markers:
\itemize{
\item NLR  = neutrophils / lymphocytes
\item PLR  = platelets / lymphocytes
\item LMR  = lymphocytes / monocytes
\item dNLR = neutrophils / (WBC - neutrophils) when WBC available
\item SII  = platelets * neutrophils / lymphocytes
\item SIRI = neutrophils * monocytes / lymphocytes
\item AISI = neutrophils * monocytes * platelets / lymphocytes
\item CRP_category: "low" (<1 mg/L), "moderate" (1–3 mg/L), "high" (>3 mg/L) when CRP available
\item Eosinophil-panel extras: NER = neutrophils / eosinophils; PIV = platelets\emph{neutrophils}monocytes/lymphocytes;
CLR = CRP/lymphocytes; CAR = CRP/albumin; PCR = platelets/CRP; mGPS (CRP, albumin); ESR passthrough.
}
}
\examples{
df <- data.frame(
  neutrophils = c(4, 2),
  lymphocytes = c(2, 0),
  monocytes   = c(0.5, 0.3),
  platelets   = c(200, 150),
  WBC         = c(7, 4.5),
  CRP         = c(2.5, 0.8),
  albumin     = c(40, 42),
  eosinophils = c(0.2, 0.1),
  ESR         = c(12, 15)
)
cm <- list(
  neutrophils = "neutrophils", lymphocytes = "lymphocytes", monocytes = "monocytes",
  platelets = "platelets", WBC = "WBC", CRP = "CRP", albumin = "albumin",
  eosinophils = "eosinophils", ESR = "ESR"
)
# Classic panel (no eosinophils key)
classic_cm <- cm; classic_cm$eosinophils <- NULL; classic_cm$ESR <- NULL
inflammatory_markers(df, classic_cm, panel = "classic", na_action = "keep")
# Eosinophil panel
inflammatory_markers(df, cm, panel = "eos", na_action = "keep",
                     check_extreme = TRUE, extreme_action = "cap", verbose = TRUE)

}
\references{
Zahorec R. Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress.
Bratisl Lek Listy. 2001;102(1):5–14.
Templeton AJ, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
J Natl Cancer Inst. 2014;106(6):dju124.
Hu B, et al. Systemic immune-inflammation index predicts prognosis of patients with hepatocellular carcinoma.
Ann Surg Oncol. 2014;21(11):3819–27.
Qi Q, et al. SIRI: a novel systemic inflammation response index for predicting survival in pancreatic cancer.
Ann Surg Oncol. 2016;23(2):559–568.
Fois AG, et al. The AISI (aggregate index of systemic inflammation) in COPD. Multidiscip Respir Med. 2020;15:35.
Proctor MJ, et al. Systemic inflammation-based prognostic scores in cancer: the Glasgow Prognostic Score (mGPS).
Br J Cancer. 2011;104(4):726–734.
Pearson TA, et al. Markers of inflammation and CVD: CDC/AHA statement. Circulation. 2003;107(3):499–511.
}
